On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
We have now added a new section called the "Assay History List" to the "At A Gla...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...